< Terug naar vorige pagina
Onderzoeker
Ruben Faelens
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Farmacotechnologie en Biofarmacie (Afdeling)
Lid
Vanaf7 nov 2017 → 12 sep 2022
Projecten
1 - 1 of 1
- Ontwikkeling van tool voor computergestuurd doseringsadvies: algemeen framework, haalbaarheidsstudie en proof of concept voor tacrolimusVanaf1 nov 2017 → 7 sep 2022Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 8 van 8
- Computer-assisted dosing recommendation framework, feasibility study and proof of concept implementation for tacrolimus(2022)
Auteurs: Ruben Faelens, Pieter Annaert, Dirk Kuypers
- Erdafitinib's effect on serum phosphate justifies its pharmacodynamically guided dosing in patients with cancer(2022)
Auteurs: Ruben Faelens
Pagina's: 569 - 580 - Predicting model-informed precision dosing: A test-case in tacrolimus dose adaptation for kidney transplant recipients(2022)
Auteurs: Ruben Faelens, Dirk Kuypers, Pieter Annaert
Pagina's: 348 - 361 - Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis(2021)
Auteurs: Ruben Faelens, Zhigang Wang, Paul Declerck, Marc Ferrante, Séverine Vermeire, Erwin Dreesen
- Glomerular Filtration Rate in Asphyxiated Neonates Under Therapeutic Whole-Body Hypothermia, Quantified by Mannitol Clearance(2021)
Auteurs: Neel Deferm, Ruben Faelens, Anne Smits, Pieter Annaert, Karel Allegaert
Pagina's: 897 - 906 - Spatiotemporal imaging and pharmacokinetics of fluorescent compounds in zebrafish eleuthero-embryos after different routes of administration(2021)
Auteurs: Marlly Guarin, Ruben Faelens, Deirdre Cabooter, Pieter Annaert, Peter de Witte, Annelii Ny
- Optimising infliximab induction dosing for patients with ulcerative colitis(2019)
Auteurs: Erwin Dreesen, Ruben Faelens, Gert Van Assche, Marc Ferrante, Séverine Vermeire, Ann Gils, Thomas Bouillon
Pagina's: 782 - 795 - ADAPTIVE DOSING DURING INFLIXIMAB INDUCTION THERAPY CAN IMPROVE MUCOSAL HEALING RATES IN PATIENTS WITH ULCERATIVE COLITIS(2018)
Auteurs: Erwin Dreesen, Ruben Faelens, Gert A Van Assche, Marc Ferrante, Severine Vermeire, Ann Gils, Thomas Bouillon
Pagina's: S823 - S823